These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19589890)

  • 1. Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.
    Garcia-Gonzalez E; Selvi E; Balistreri E; Lorenzini S; Maggio R; Natale MR; Capecchi PL; Lazzerini PE; Bardelli M; Laghi-Pasini F; Galeazzi M
    Rheumatology (Oxford); 2009 Sep; 48(9):1050-6. PubMed ID: 19589890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model.
    Balistreri E; Garcia-Gonzalez E; Selvi E; Akhmetshina A; Palumbo K; Lorenzini S; Maggio R; Lucattelli M; Galeazzi M; Distler JW
    Ann Rheum Dis; 2011 Apr; 70(4):695-9. PubMed ID: 21177293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes.
    Selvi E; Lorenzini S; Garcia-Gonzalez E; Maggio R; Lazzerini PE; Capecchi PL; Balistreri E; Spreafico A; Niccolini S; Pompella G; Natale MR; Guideri F; Laghi Pasini F; Galeazzi M; Marcolongo R
    Clin Exp Rheumatol; 2008; 26(4):574-81. PubMed ID: 18799087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.
    Lazzerini PE; Natale M; Gianchecchi E; Capecchi PL; Montilli C; Zimbone S; Castrichini M; Balistreri E; Ricci G; Selvi E; Garcia-Gonzalez E; Galeazzi M; Laghi-Pasini F
    J Mol Med (Berl); 2012 Mar; 90(3):331-42. PubMed ID: 22033526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
    García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
    Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
    Scholl A; Ivanov I; Hinz B
    Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
    Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
    J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.
    Feng YJ; Li YY; Lin XH; Li K; Cao MH
    World J Gastroenterol; 2016 Nov; 22(43):9515-9524. PubMed ID: 27920472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
    Rahn EJ; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for cannabinoid therapies in viral encephalitis.
    Solbrig MV; Fan Y; Hazelton P
    Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
    Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
    J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells.
    Echigo R; Sugimoto N; Yachie A; Ohno-Shosaku T
    Oncol Rep; 2012 Oct; 28(4):1176-80. PubMed ID: 22842590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
    Gustafsson K; Christensson B; Sander B; Flygare J
    Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis.
    Petrella C; Agostini S; Alema' GS; Casolini P; Carpino F; Giuli C; Improta G; Linari G; Petrozza V; Broccardo M
    Neurogastroenterol Motil; 2010 Nov; 22(11):1248-56, e323. PubMed ID: 20659297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1.
    Kong Y; Wang W; Zhang C; Wu Y; Liu Y; Zhou X
    Mol Med Rep; 2016 Jun; 13(6):4569-76. PubMed ID: 27082728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists.
    Ribeiro R; Wen J; Li S; Zhang Y
    Prostaglandins Other Lipid Mediat; 2013 Jan; 100-101():1-14. PubMed ID: 23219970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects.
    de Lago E; Moreno-Martet M; Cabranes A; Ramos JA; Fernández-Ruiz J
    Neuropharmacology; 2012 Jun; 62(7):2299-308. PubMed ID: 22342378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
    Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
    J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.